Podcast episode 120 (in German)
Probiotics after antibiotics – the pack next to the prescription
October 28, 2026
The pack for the gut flora next to the antibiotic is a classic. The most precise study on it, with colonoscopy and tissue samples in 21 adults, found the slowest recovery precisely with the capsule — and yet this is not an episode against probiotics.
What it is about
Probiotics are live microorganisms, mostly lactobacilli and bifidobacteria, and what is supported applies to one strain for one question, not to the pack. At the center is an experiment that compared 3 routes back after 7 days of antibiotics: a commercially available product with 11 strains, nothing at all, or the person’s own stool, frozen beforehand. The capsule group recovered the slowest — not because the product failed, but because the strains settle particularly well after the antibiotic and thereby occupy the place of the body’s own flora. The episode sets against this the controlled data on antibiotic-associated diarrhea, where probiotics perform well in children. The conclusion is the separation of two questions that are usually mixed up at the shelf.
Key points
- With the person’s own stool, frozen beforehand, the gut flora returned almost completely within days, without treatment in about 3 weeks; after 4 weeks of capsules with 11 strains it remained markedly delayed.
- The delay affected bacteria and gene activity of the gut wall equally and, according to reviews, lasted up to 5 months; the full text of the study is behind a paywall.
- The same samples showed 3 years later: without antibiotics, the product lowered the number of resistance genes; after antibiotics, it increased them — via species from the person’s own gut, not from the capsule.
- The groups were small: 8 people received the capsules, 6 their own stool, 7 nothing, allocated rather than randomized and without blinding.
- A Cochrane review of 33 randomized trials with 6,352 children found antibiotic-associated diarrhea in 8 percent with probiotics versus 19 percent without.
- In 2,941 evaluated older hospital patients in Britain, blinded and with a placebo, the rates were 10.8 and 10.4 percent — no difference.
Where the data stop
The colonoscopy study comprises 21 people, one product and one antibiotic setting; one of the arms had 6 people. Microbiome and gene activity were measured, not how participants fared over months; nobody asked about symptoms. The capsules came after the antibiotic; in everyday life they are usually taken at the same time. The study thus raises a question; it does not answer it for everyone. The mechanism behind it — better adhesion after the antibiotic, plus substances from lactobacilli that inhibited the body’s own microbiome in the test tube — fits the finding but is not a result in its own right.
Conversely, it does not refute the diarrhea data, because it did not record this endpoint at all. There, the benefit applies to children with certain strains; in older hospital patients with other strains it did not show; the direction therefore remains mixed. Where a specific strain has been prescribed by a doctor, an episode changes nothing about that, and for immunocompromised people, recent transplant recipients and the seriously ill, explicitly different rules apply.
Listen (in German)
Listen on Spotify Listen on Apple Podcasts Listen on Amazon Music
Published on October 28, 2026.
The topic in the database
- The evidence applies to one strain in one indication, not to the product class. It is densest for antibiotic-associated diarrhea.Probiotics
All episodes in the app (German)
Information only, not medical advice and not a usage or dosage recommendation. Prescription-only and unapproved substances belong in the hands of a physician. Last updated: 2026-09-22.